Demand for high quality AAV vectors continues to grow, as the number of #genetherapy trials and approvals increases. Let's do a #TBT to the American Society of Gene & Cell Therapy, where our team presented 11 posters at the event! Poster 561 showed how our EpyQ system combines with our suspension HEK293 cell line to create a robust and scalable platform for high quality AAV vector manufacturing.
Ascend Advanced Therapies’ Post
More Relevant Posts
-
Don’t forget to attend our sponsored session at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting on Friday, May 10 from 8-8:30 a.m. EDT. This session will cover how strategic collaborations between #CDMOs and #CROs are addressing industry challenges related to #viralvector production, leading to: - Improved AAV production titer with a significant reduction in cost of goods via high-throughput processes and analytical development - Direct scale-up from bench to 2,000L - Strategies for enhancing % full enrichment during downstream processing - Developing customer-centric analytics for viral vector characterization in development and GMP settings Learn more about this sponsored session here: http://spr.ly/6047jdT23
-
Check out our latest work on in vivo engineering of T cells for CAR-T therapy in poster P453 at #ESGCT tomorrow. Thanks to Nick for presenting! #invivoCART #invivoengineering #immunotherapy #genetherapy
We're looking forward to attending the European Society of Gene and Cell Therapy (ESGCT) 2023 Conference in Brussels later this month where we will be presenting 5 posters. If you would like to learn more about our platform technologies, please visit our posters being presented by our team members, or please email partnering@oxb.com to set up a meeting. #ESGCT2023 #Conference #CDMO #ViralVectorManufacturing #CellAndGeneTherapies #LentiViralVectors
-
-
Introducing our stellar lineup of speakers for the BioCon Asia-ACGT Conference, featuring trailblazers in gene and cell therapy. These experts are shaping the future of healthcare and making waves in their respective fields. Don't miss the chance to learn from the best! 🌟🧬 Act fast and grab your early bird and group tickets now for a limited time! Scan the QR code for more details and to secure your spot at this groundbreaking event. 🚀🎟️ #BioConAsiaACGT #GeneTherapy #CellTherapy #HealthcareInnovation #BioConAsiaACGT #GeneTherapy #CellTherapy #HealthcareInnovation
-
-
Per the 2022 TEConomy report, North Carolina’s growth as a #lifesciences hub has outpaced most U.S. life science hubs. This growth builds on the state's strengths in #biomanufacturing, gene and cell therapy, #clinicalresearch, and #AgTech. Read more at: https://hubs.ly/Q0216yBV0
-
-
We are live at #ESGCT! Come by booth #17 to discover how Merck can help you develop your Viral Vector production process 🚀
Are you at #ESGCT2023? Be sure to connect with Thorsten Platz, BSc, MRSC Felix Kreher Ghislaine Mullan Pau Ferran Roca at booth #17 to learn more about how we can support you in accelerating your gene or cell therapy to patients!
-
-
Associate Professor, University Faculty Scholar - CTO at LigaTrap™ Technologies, LLC
NC-VVIRAL is at BPI 2023 (https://vviral.ncsu.edu/) - Booth 1354 Come visit us to discuss Strategic Partnerships. We customize solutions to improve Upstream, Downstram, and Analytical Characterization of Viral Vectors for Gene and Cell Therapy. #viralvectors #genetherapy #upstream #downstreamprocessing #processanalytics #cellculture #chromatography
-
-
🎙️🎧 From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II) In this episode, Fierce Pharma's Fraiser Kansteiner sits down with Delara Motlagh, head of cell therapy at Catalent Pharma Solutions; Becky Butler Cap, senior vice president of biotherapies at Vitalant; and Kevin Kyle, CEO of Germfree. Together, they discuss cell collection, the critical first step in advanced therapy manufacturing, and the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and eventually to the market. Listen below ⬇️🎧 #CellGeneTherapy #CGT #CellandGeneTherapies
From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II)
-
Heading to ASGCT in Baltimore? Come get your groove on at booth #730 or check out our talk to learn how Stunner and Leprechaun can help you bust through bottlenecks in your gene and cell therapy workflows! #ASGCT2024!
-
Landmark Bio’s Eli Kraus, Yun Chen,Ph.D., Manish Tandon and Gregg Nyberg, demonstrate application of a rapid analytical method in cutting-edge Extracellular Vesicle (EV)-based therapy biomanufacturing. Based on widely available conventional Flow Cytometer configurations, the method development was presented at the ECI Advancing Manufacture of Cell and Gene Therapies Conference in Coronado, CA. Read about the accuracy, precision, and reliable EV quantitation by Flow Cytometry, its benefit, criticality, and limitation in directly supporting clinical EV biomanufacturing platforms. #ExtracellularVesicles #FlowCytometry
-
🎙️🎧 From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II) In this episode, Fierce Pharma's Fraiser Kansteiner sits down with Delara Motlagh, head of cell therapy at Catalent Pharma Solutions; Becky Butler Cap, senior vice president of biotherapies at Vitalant; and Kevin Kyle, CEO of Germfree. Together, they discuss cell collection, the critical first step in advanced therapy manufacturing, and the importance of locking in process decisions early and how to effectively scale projects from the lab to the clinic and eventually to the market. Listen below ⬇️🎧 #CellGeneTherapy #CGT #CellandGeneTherapies
From cell collection to commercial contracting: Advancements in cell & gene therapy manufacturing (Part II)
